Thus, our study indicates that high IL-35 levels in colorectal cancer promotes the increased production of IL-35 via STAT1 and STAT3 and results in the suppression of T cell proliferation, leading to tumor immunotolerance. The gene discussed is STAT3; the disease is neoplasm.